|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/216 | (2006.01) |
| A61K 9/19 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2928463 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13849763.1 |
| Date of filing the European patent application | 2013-10-24 | |
| (97) | Date of publication of the European application | 2015-10-14 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-20 |
| (46) | Date of publication of the claims translation | 2020-02-10 |
| (86) | Number | PCT/SE2013/051246 |
| Date | 2013-10-24 |
| (87) | Number | WO 2014/065751 |
| Date | 2014-05-01 |
| (30) | Number | Date | Country code |
| 1251211 | 2012-10-26 | SE | |
| 201261719184 P | 2012-10-26 | US |
| (72) |
SPIRA, Jack, SE
LEHMANN, Fredrik, SE
|
| (73) |
Oncopeptides Innovation AB,
Luntmakargatan 46, 111 37 Stockholm,
SE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Liofilizuoti melfalano flufenamido preparatai |
| LYOPHILIZED PREPARATIONS OF MELPHALAN FLUFENAMIDE |
| Payment date | Validity (years) | Amount | |
| 2024-09-23 | 12 | 289.00 EUR |
| 2025-10-24 |